Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer
- 31 May 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 101 (2) , 287-295
- https://doi.org/10.1016/j.ygyno.2005.10.040
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinomaThe Journal of Pathology, 2005
- Genetic Variation in the Progesterone Receptor Gene and Ovarian Cancer RiskAmerican Journal of Epidemiology, 2005
- Clarifying the PROGINS Allele Association in Ovarian and Breast Cancer Risk: A Haplotype-Based AnalysisJNCI Journal of the National Cancer Institute, 2005
- A Germline Variation in the Progesterone Receptor Gene Increases Transcriptional Activity and May Modify Ovarian Cancer RiskJournal of Clinical Endocrinology & Metabolism, 2004
- Association of progesterone receptor polymorphism with recurrent abortionsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2004
- A mutated progesterone receptor allele is more prevalent in unexplained infertilityFertility and Sterility, 2003
- A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer riskProceedings of the National Academy of Sciences, 2002
- Analysis of the human progesterone receptor gene polymorphism PROGINS in Austrian ovarian cancer patientsInternational Journal of Cancer, 2002
- Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based studyGenetic Epidemiology, 2001
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999